Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Climb Bio (CLYM) Return on Capital Employed (2021 - 2026)

Climb Bio filings provide 6 years of Return on Capital Employed readings, the most recent being 38.51% for Q1 2026.

  • Quarterly Return on Capital Employed rose 1202.0% to 38.51% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 38.51% through Mar 2026, up 1202.0% year-over-year, with the annual reading at 36.6% for FY2025, 1502.0% up from the prior year.
  • Return on Capital Employed hit 38.51% in Q1 2026 for Climb Bio, up from 40.4% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 18.55% in Q1 2024 and bottomed at 50.53% in Q1 2025.
  • Average Return on Capital Employed over 5 years is 36.14%, with a median of 37.03% recorded in 2023.
  • The largest annual shift saw Return on Capital Employed soared 2629bps in 2024 before it tumbled -3198bps in 2025.
  • Climb Bio's Return on Capital Employed stood at 34.24% in 2022, then decreased by -8bps to 37.03% in 2023, then decreased by -3bps to 38.19% in 2024, then decreased by -6bps to 40.4% in 2025, then increased by 5bps to 38.51% in 2026.
  • Per Business Quant, the three most recent readings for CLYM's Return on Capital Employed are 38.51% (Q1 2026), 40.4% (Q4 2025), and 32.62% (Q3 2025).